Eagle Capital Management LLC Bausch Health Companies Inc. Transaction History

Eagle Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $215,344 - $258,516	-8,600 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $183,782 - $295,668	8,600 New	8,600 $273,000
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $111,628 - $260,150	-8,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $162,454 - $274,254	8,600 New	8,600 $257,000
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $179,568 - $220,676	-8,600 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $173,978 - $226,094	8,600 New	8,600 $212,000
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $151,704 - $243,552	-8,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $177,504 - $220,762	8,600 New	8,600 $221,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.72B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Eagle Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Capital Management LLC with notifications on news.